5/1/2008

The FDA has approved the use of GlaxoSmithKline's Advair Diskus in patients who experience flare-ups of chronic obstructive pulmonary disease, which can cause bronchitis and emphysema. The drug is already approved to treat wheezing and other milder symptoms of the disease.

Full Story:
Forbes, Reuters

Related Summaries